Susquehanna International Group’s Grace Therapeutics GRCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
2024
Q2
$113K Buy
2024
Q1
$126K Buy
2022
Q3
Sell
2022
Q2
$22K Buy
2020
Q4
Sell
2020
Q3
$12K Buy
2018
Q1
Sell
2017
Q4
$528K Buy
2015
Q1
Sell
2014
Q4
$12K Buy